YTTRIUM SUBSTITUTED BARIUM THIOALUMINATE PHOSPHOR MATERIALS

Details for Australian Patent Application No. 2003212168 (hide)

Owner IFIRE TECHNOLOGY INC.

Inventors CHEONG, Dan, Daeweon; NAKUA, Abdul, M.

Pub. Number AU-A-2003212168

PCT Number PCT/CA03/00424

PCT Pub. Number WO2003/081957

Priority 60/367,510 27.03.02 US

Filing date 24 March 2003

Wipo publication date 8 October 2003

International Classifications

H05B 033/14 Electroluminescent light sources - characterised by the chemical or physical composition or the arrangement of the electroluminescent material

C09K 011/84 Luminescent, e.g. electroluminescent, chemiluminescent, materials

H05B 033/22 Electroluminescent light sources - characterised by the chemical or physical composition or the arrangement of auxiliary dielectric or reflective layers

H05B 033/26 Electroluminescent light sources - characterised by the composition or arrangement of the conductive material used as an electrode

Event Publications

24 July 2003 Complete Application Filed

  Priority application(s): 60/367,510 27.03.02 US

13 November 2003 Application Open to Public Inspection

  Published as AU-A-2003212168

16 December 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003212169-PURIFICATION OF PROTEINS USING IONIC SURFACTANTS AND POLAR SOLVENTS

2003212167-COMPOUNDS AND USE THEREOF FOR THE TREATMENT OR PREVENTION OF THROMBOCYTHEMIA